AI-generated summary
The authors report a randomized, placebo-controlled trial of 120 breast cancer patients receiving radiotherapy, comparing laser therapy with placebo. At the end of radiotherapy, a larger share of placebo patients had moderate or severe skin reactions (30% versus 6.7%), and the authors describe laser therapy as effective at preventing these reactions.
- Participants
- 120
- Who or what was studied
- Breast cancer patients undergoing radiotherapy after lumpectomy
- Wavelengths
- 808, 905 nm
- Limits stated in the abstract
- The abstract does not describe a long-term follow-up period or the certainty of the findings beyond the reported group comparisons.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808-905 nm
- Energy density (fluence)
- 4 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Placebo-controlled, Laser, Photobiomodulation therapy, Dose, GRADE, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.